Industry News
Tanning Rehab? Brain's Addiction Related To Alcoholism, Drug Abuse
Aug 12, 2011
Melanoma is a killer. So is alcoholism and drug abuse. Did you ever think they were connected? A new study shows that the brains of people who say they're addicted to tanning act a lot like those of alcoholics and drug addicts. Maybe tanning rehab centers should be opening close to beaches nationwide. Tanning comes with many health risks... Read More
Genetically Modified 'Serial Killer' T Cells Obliterate Tumors In Leukemia Patients
Aug 12, 2011
In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells... Read More
Trastuzumab Raises Risk Of Heart Problems In The Elderly With History Of Heart Disease Or Diabetes
Aug 12, 2011
The first study to investigate the effect of the breast cancer drug trastuzumab (Herceptin) on heart and vascular function in elderly patients has found that it increases the risk of heart problems, particularly in women with a history of heart disease, diabetes or both... Read More
Analysis Of Metabolites Reveals Need For Gender-Specific Therapies
Aug 11, 2011
Scientists at the Helmholtz Zentrum München have agreed in a study that will be published on August 11 in the open-access journal PLoS Genetics, that there is a need for gender-specific therapies after analyzing the metabolic profile of blood serum revealed significant differences in metabolites between men and women... Read More
Leukemia Breakthrough - Serial Killer T Cells Wipe Out Tumors In Small Trial
Aug 11, 2011
In a small trial of advanced chronic lymphocytic leukemia (CLL) patients, genetically modified versions of their own T cells behaved like "serial killers" and hunted down and obliterated tumors, resulting in sustained remissions of up to a year... Read More
Blood Tests For Active TB Not Accurate Or Cost-Effective
Aug 11, 2011
Commercial blood serum antibody tests widely used in India and other developing countries to diagnose active tuberculosis are not accurate or cost-effective, according to an analysis by researchers at the Johns Hopkins Bloomberg School of Public Health, the University of Washington School of Public Health and McGill University... Read More
Penn Study On Silencing Of Tumor Suppressor Gene Suggests New Target For Lymphoma
Aug 11, 2011
Mariusz A. Wasik, MD, professor of Pathology and Laboratory Medicine, and Qian Zhang, MD, PhD, research assistant professor, both from the Perelman School of Medicine at the University of Pennsylvania, and their colleagues, found that a cancer-causing fusion protein works by silencing the tumor suppressor gene IL-2R common gamma-chain (IL-2Rγ)... Read More
Breast Cancer Drug Herceptin Raises Heart Risk, Especially For Those With Diabetes Or Heart Disease History
Aug 10, 2011
In a first study, researchers assessed the effect of the breast cancer drug trastuzumab (Herceptin) on heart and vascular function in elderly patients and discovered an increased risk of heart problems, particularly affecting women with a history of heart disease, diabetes or both. The study has been published in the cancer journal Annals of Oncology... Read More
Combining IVF With Asprin Use, Study Finds No Evidence To Support It
Aug 10, 2011
Published in The Cochrane Library, an organized study found no convincing evidence to support the routine use of aspirin in women being treated for IVF. Taking aspirin during an IVF cycle did not appear to improve the chances of becoming pregnant, researchers reported. IVF treatment combined with the use of aspirin is controversial... Read More
Study Urges Caution With Lenalidomide Dosage
Aug 10, 2011
An early phase multiple myeloma trial has unexpectedly revealed that the drug lenalidomide interacts with another protein in cells that affect its dose level in the body, say researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) who conducted the study... Read More
Previous Page Next Page